Stem-Cell Research Stocks Are Risky for Investors
Deseret News (Salt Lake City) › September 19, 2004
Linked as:
Summary
Whether stem-cell research will be a determining issue in the presidential election remains to be seen.
But here's a return that's already in and counted: Stem-cell research has become the focus of a long-running controversy that pits scientific potential against beliefs about the beginnings of life.See the full content of this document
Extract
Stem-Cell Research Stocks Are Risky for Investors
On the investment side, the fledgling stem-cell companies, their executives and potential investors have a lot at stake in this heated public debate.
They've seen once-obscure biotechnology firms use their research to reduce AIDS from a certain death sentence to a chronic dise...See the full content of this document
Sponsored links
